Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2,355 GBp
Change Today -29.00 / -1.22%
Volume 109.7K
SYR On Other Exchanges
Symbol
Exchange
OTC US
As of 11:35 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

synergy health plc (SYR) Snapshot

Open
2,369 GBp
Previous Close
2,384 GBp
Day High
2,385 GBp
Day Low
2,353 GBp
52 Week High
04/15/15 - 2,426 GBp
52 Week Low
05/16/14 - 1,215 GBp
Market Cap
1.4B
Average Volume 10 Days
134.1K
EPS TTM
0.60 GBp
Shares Outstanding
59.1M
EX-Date
11/20/14
P/E TM
39.2x
Dividend
15.78 GBp
Dividend Yield
0.67%
Current Stock Chart for SYNERGY HEALTH PLC (SYR)

Related News

No related news articles were found.

synergy health plc (SYR) Related Businessweek News

No Related Businessweek News Found

synergy health plc (SYR) Details

Synergy Health plc provides outsourced sterilization services for medical device manufacturers, hospitals, and other industries worldwide. The company operates through the UK & Ireland, Europe & the Middle East, Asia & Africa, and the Americas segments. It offers hospital sterilization services for reusable medical and surgical equipment used in operating theatres. The company also provides a range of sterilization technologies, including gamma irradiation; electron, ion, and X-ray beam treatments; and ethylene oxide sterilization solutions for the medical devices, pharmaceuticals, and industrial sectors. In addition, it offers reusable surgical solutions comprising gowns, towels, and stainless products to hospitals and surgery centers; and laboratory services, including hematology, immunology, biochemistry, microbiology, environmental monitoring, and substance identification, as well as drug and alcohol testing services. Further, the company provides pharmaceutical laboratories for chemical and microbiological analysis; linen management services for healthcare facilities. Additionally, it offers infection prevention and control products, such as disinfectants, detergent wipes, cleaning and disinfection products, anti microbial hand sanitizing mousse, clinical waste containers, and sharps; patient hygiene solutions, including skin cleansings and bed bath systems; and custom procedure packs and trays, single use instruments, consumables, X ray detectable swabs, and bags for endoscopic retrieval of tissue. The company also offers wound care solutions, including tubular bandages, garments, and hosiery and liner kits; and IT services. Synergy Health plc was founded in 1991 and is headquartered in Swindon, the United Kingdom.

5,005 Employees
Last Reported Date: 06/30/14
Founded in 1991

synergy health plc (SYR) Top Compensated Officers

Group Chief Executive Officer, Member of Seni...
Total Annual Compensation: 823.0K GBP
Group Finance Director, Member of Senior Exec...
Total Annual Compensation: 494.0K GBP
Compensation as of Fiscal Year 2014.

synergy health plc (SYR) Key Developments

Synergy Reports Interim Management Statement for the Nine Months to December 28, 2014

Synergy reported interim management statement for the nine months to December 28, 2014. For the nine months, the company's revenue increased by 5.7% to £303.1 million compared to £286.9 million in last year. Underlying revenue, excluding currency effects, increased by 9.6%. Growth has been building throughout the year, with third quarter underlying revenues before currency effects up 14.2% on the same period in 2013.

Synergy Health plc Announces Interim Management Statement for the Third Quarter and Nine Months Ended 28 December 2014

Synergy Health plc announced interim management statement for the third quarter and nine months ended 28 December 2014. For the quarter, the company reported revenue of £105.6 million against £94.7 million a year ago. For the nine months, the company reported revenue of £303.1 million against £286.9 million a year ago. Underlying revenue, excluding currency effects, increased by 9.6%.

Synergy Health plc Reports Parent Earnings Results for the Six Months Ended September 28, 2014

Synergy Health plc reported parent earnings results for the six months ended September 28, 2014. The company has reported that profit attributable to equity holders of the parent for the first six months ended September 28, 2014 was GBP 18.28 million, or 30.75 pence per diluted share, compared to GBP16.86 million, or 28.27 pence per diluted share, for the same period ended September 29, 2013. Revenue for the first six months ended September 28, 2014 was GBP 197.51 million, compared to GBP 192.13 million for the same period ended September 29, 2013. Gross profit for the first six months ended September 28, 2014 was GBP 86.95 million, compared to GBP 76.88 million for the same period ended September 29, 2013. Profit before tax for the first six months ended September 28, 2014 was GBP 24.66 million, compared to GBP 21.36 million for the same period ended September 29, 2013. The strong first half financial performance demonstrates success in driving value-enhancing healthcare services for customer base. The proposed combination with STERIS will further drive uptake of services delivering value for current and new customers.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYR:LN 2,355.00 GBp -29.00

SYR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Almirall SA €16.98 EUR -0.02
Ironwood Pharmaceuticals Inc $15.11 USD -0.37
Nektar Therapeutics $10.77 USD -0.29
Sucampo Pharmaceuticals Inc $21.09 USD -0.31
Theravance Inc $17.92 USD +0.46
View Industry Companies
 

Industry Analysis

SYR

Industry Average

Valuation SYR Industry Range
Price/Earnings 37.0x
Price/Sales 3.4x
Price/Book 3.8x
Price/Cash Flow 29.7x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGY HEALTH PLC, please visit www.synergyhealthplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.